Trinity Biotech (TRIB) Net Margin Growth (3y) (2012 - 2024)

Trinity Biotech (TRIB) Net Margin Growth (3y) (2012 - 2024) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Margin Growth (3y) (Qtr)
1 Abbott Laboratories 201.40 Bn 194.75 Bn 6.27 Bn -388.00
2 Stryker 122.29 Bn 119.41 Bn 3.81 Bn -1.00
3 Medtronic 105.01 Bn 96.40 Bn 6.41 Bn -108.00
4 Boston Scientific 64.81 Bn 63.59 Bn 3.61 Bn 1,692.00
5 Edwards Lifesciences 55.28 Bn 51.60 Bn 1.29 Bn -
6 Dexcom 29.06 Bn 27.94 Bn 750.30 Mn 1,018.00
7 Koninklijke Philips 29.02 Bn 25.93 Bn 2.07 Bn 1,978.00
8 GE HealthCare Technologies 28.27 Bn 26.20 Bn 1.98 Bn 399.00
9 Smith & Nephew 25.80 Bn 25.22 Bn - -
10 Trinity Biotech 93,750.00 -5.04 Mn - -

Historic Data

Download Data
DateValue
Dec 31, 2024 -10,045.00
Sep 30, 2024 -3,741.00
Jun 30, 2024 -3,962.00
Mar 31, 2024 -2,882.00
Dec 31, 2023 -1,038.00
Sep 30, 2023 -6,867.00
Jun 30, 2023 -3,393.00
Mar 31, 2023 -2,868.00
Dec 31, 2022 -6,410.00
Sep 30, 2022 -5,706.00
Jun 30, 2022 -3,827.00
Mar 31, 2022 -7,738.00
Dec 31, 2021 -647.00
Sep 30, 2021 222.00
Jun 30, 2021 -545.00
Mar 31, 2021 467.00
Dec 31, 2020 -3,059.00
Sep 30, 2020 2,114.00
Jun 30, 2020 -1,270.00
Mar 31, 2020 -1,579.00